Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)

被引:1
|
作者
Wong, Hui-li
Karasinska, Joanna M.
Jones, Martin
Eirew, Peter
Schrader, Kasmintan
Lim, Howard
Shen, Yaoqing
Jones, Steven
Yip, Stephen
Laskin, Janessa
Marra, Marco
Schaeffer, David F.
Renouf, Daniel J.
机构
关键词
D O I
10.1158/1538-7445.PANCA16-B81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B81
引用
收藏
页数:2
相关论文
共 50 条
  • [21] PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
    Palloma Porto Almeida
    Cristina Padre Cardoso
    Leandro Martins de Freitas
    BMC Cancer, 20
  • [22] Exploring gene expression levels in Pancreatic Ductal Adenocarcinoma (PDAC) using RNA-Seq data
    Jaiswal, Alokita
    Aier, Imlimaong
    2018 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2018, : 203 - 206
  • [23] The utility of PD-L1 as a prognostic marker in pancreatic ductal adenocarcinoma (PDAC).
    Wu, Linda
    Fulop, Daniel Jeremy
    Rudshteyn, Michelle
    Shah, Nagma
    Hill-Oliva, Michael
    Sohval, Sophie
    Gandhi, Sonal
    Chowdhury, Nobel
    Debnath, Neha
    Cohen, Deirdre Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 753 - 753
  • [24] Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
    Javed, Muhammad Ahsan
    Beyer, Georg
    Le, Nha
    Vinci, Alessio
    Wong, Helen
    Palmer, Daniel
    Morgan, Robert D.
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Alam, Salma
    Chowdhury, Sumsur
    Ma, Yuk Ting
    Archibugi, Livia
    Capurso, Gabriele
    Maisonneuve, Patrick
    Neesse, Albrecht
    Sund, Malin
    Schober, Marvin
    Krug, Sebastian
    PANCREATOLOGY, 2019, 19 (01) : 97 - 104
  • [25] A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
    Chan, Kai Siang
    Ho, Bernard Chi Shern
    Shelat, Vishal G.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [26] Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
    Rekin’s Janky
    Maria Mercedes Binda
    Joke Allemeersch
    Anke Van den broeck
    Olivier Govaere
    Johannes V. Swinnen
    Tania Roskams
    Stein Aerts
    Baki Topal
    BMC Cancer, 16
  • [27] miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
    Tesfaye, Anteneh A.
    Azmi, Asfar S.
    Philip, Philip A.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (01): : 58 - 70
  • [28] Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
    Janky, Rekin's
    Binda, Maria Mercedes
    Allemeersch, Joke
    Van den Broeck, Anke
    Govaere, Olivier
    Swinnen, Johannes V.
    Roskams, Tania
    Aerts, Stein
    Topal, Baki
    BMC CANCER, 2016, 16
  • [29] Prognostic value of the Memorial Sloan Kettering (MSK) prognostic score (MPS) in pancreatic ductal adenocarcinoma (PDAC).
    Lebenthal, Justin
    Zheng, Junting
    Glare, Paul A.
    O'Reilly, Eileen Mary
    Epstein, Andrew S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [30] The Beginning of the End of Nihilism in Pancreatic Ductal Adenocarcinoma (PDAC)?
    Johnson, K. M.
    Firpo, M. A.
    Boucher, K. M.
    Scaife, C. L.
    Mulvihill, S. J.
    PANCREAS, 2013, 42 (08) : 1357 - 1357